Persistent cAMP-signals triggered by internalized G-protein-coupled receptors.

Calebiro D, Nikolaev VO, Gagliani MC, de Filippis T, Dees C, Tacchetti C, Persani L, Lohse MJ. · 2009

Read Persistent cAMP-signals triggered by internalized G-protein-coupled receptors. by Calebiro D, Nikolaev VO, Gagliani MC, de Filippis T, Dees C, Tacchetti C, Persani L, Lohse MJ. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2718703.txt.

Introduction

Calebiro and co-authors showed in 2009 that a hormone receptor can keep signaling after it is pulled inside the cell, against the standard model. G-protein-coupled receptors were thought to signal only at the cell surface, then switch off as they are internalized. They watched the thyroid stimulating hormone receptor in living native cells in real time.

The receptor kept producing cAMP, a key internal signal, well after internalization, in a persistent phase that surface signaling cannot explain. Internalized receptors thus stay active and may drive the long phase of the response. That finding reshapes how this huge receptor family, a major drug target group, is understood to work in space and time.

Catalog record

CREATORCalebiro D, Nikolaev VO, Gagliani MC, de Filippis T, Dees C, Tacchetti C, Persani L, Lohse MJ.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE125 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC2718703

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Persistent cAMP-Signals Triggered by Internalized G-Protein–Coupled Receptors By Davide Calebiro, Viacheslav O Nikolaev, Maria Cristina Gagliani, Tiziana de Filippis, Christian Dees, Carlo Tacchetti, Luca Persani, Martin J Lohse, Mark von Zastrow Published in: PLoS Biology DOI: 10.1371/journal.pbio.1000172 ABSTRACT Real-time monitoring of G-protein-coupled receptor (GPCR) signaling in native cells suggests that the receptor for thyroid stimulating hormone remains active after internalization, challenging the current model for GPCR signaling. INTRODUCTION G-protein–coupled receptor (GPCR) signaling is thought to involve a series of steps occurring at the cell surface: coupling of receptors to G-proteins, activation of G-proteins, and ultimately, triggering of G-protein-regulated effectors (i.e., adenylyl cyclase, phospholipase C, calcium channels, GIRK channels, etc.) [1]. Soon after activation, many GPCRs desensitize in a process that involves phosphorylation by G-protein–coupled receptor kinases (GRKs) and binding of β-arrestins [1]. Subsequently, most GPCRs are internalized via clathrin-coated pits or other less characterized pathways, and are either dephosphorylated and recycled back to the cell surface or targeted to lysosomes for degradation [1]. Although receptor internalization was originally considered to contribute to desensitization by reducing the number of receptors present on the cell plasma membrane, endocytosis has been subsequently and unexpectedly found to promote or even be required for receptor resensitization [1],[2]. Furthermore, novel data suggest that receptor internalization does not always lead to signal termination. This possibility has been clearly demonstrated for tyrosine kinase receptors, such as the epidermal growth factor receptor (EGFR), that were shown to continue signaling after being internalized [3]–[6]. In the case of GPCRs, instead, internalized receptors are thought capable of switching to a “nonconventional” signaling pathway, i.e., a β-arrestin-mediated activation of the mitogen-activated protein kinase (MAPK) cascade [7]. A very recent study has revealed yet another type of intracellular GPCR signaling in yeast: Gpa1, the yeast homolog of Gα can be activated by pheromone receptors on endosomes, where it stimulates phosphatidylinositol 3-phosphate production [8]. Despite such recent data, there is a current consensus that activation of canonical G-protein effectors, such as adenylyl cyclase, by GPCRs occurs exclusively at the cell surface. Describing the spatiotemporal dynamics of signaling cascades is a major goal of cell biology. In the case of GPCR signaling, this would imply answering fundamental questions such as: Where in the cell and for how long are GPCRs active after interacting with their ligands? Are there subcellular microdomains specialized for different types of GPCR-mediated signals? What are the functional consequences of GPCR internalization on signaling? Does signaling to cyclic AMP (cAMP) or other second messengers occur only at the plasma membrane, or are there additional sites of GPCR activity inside the cell? Most of these questions are still awaiting answers. The major reason for this relies on the fact that biochemical techniques, until recently the only ones available for such analyses, require cell disruption and therefore have limited temporal and, generally, no spatial resolution. To tackle those limitations, we and others have developed a series of genetically encoded fluorescent reporters that allow the direct visualization of key steps of GPCR [9]–[11] and cyclic nucleotide signaling [12]–[19], by means of microscopy techniques based on fluorescence resonance energy transfer (FRET). The introduction of these techniques has led to new insights into the mechanisms of GPCR activation and the biology of cAMP. Despite the important advance represented by the introduction of FRET-based techniques, most studies required transfection of genetically encoded fluorescent reporters into primary cells or cell lines—thus, quite far from the physiological context. This is a fundamental issue, as the type, location, and concentration of each component, as well as the size and shape of cells, are expected to greatly influence the spatiotemporal features of signaling networks [20]–[22]. To be able to study GPCR-cAMP signaling in a highly physiological context, here we generated reporter mice with ubiquitous expression of an inert fluorescent sensor for cAMP. These mice were utilized to study the dynamics of a GPCR-cAMP signaling cascade, i.e., that activated by thyroid-stimulating hormone (TSH), within the intact multicellular functional unit that constitutes thyroid tissue. RESULTS Generation of Transgenic Mice with Ubiquitous Expression of a cAMP Sensor To monitor cAMP levels in living cells and tissues, we generated transgenic mice (CAG-Epac1-camps) with ubiquitous expression of our previously described cAMP sensor (Epac1-camps) [14]. We followed the same strategy used to create green fluorescent protein (GFP) mice [23]. Instead of GFP, we cloned the Epac1-camps sequence (encompassing the yellow fluorescent protein [YFP], the cAMP binding domain of Epac1, and the cyan fluorescent protein [CFP]) under the control of the hybrid CMV enhancer/chicken β-actin (CAG) promoter (Figure 1A), and performed pronuclear injections of one-cell–stage mouse embryos with this construct. After several rounds of injections, we obtained ten PCR-positive pups, three of which showed a high level of body fluorescence and gave rise to transgenic offspring according to the Mendelian ratio. Careful analysis of isolated cells and tissues from these three lines demonstrated that two of them had a heterogeneous expression of the sensor, which was present in only 60%–80% of the cells. By contrast, the third line expressed Epac1-camps in virtually all cells and was therefore chosen for subsequent experiments. Figure 1 reproduces fluorescent images of the head and a series of organs isolated from the transgenic mice. Compared to wild-type littermates, these mice had high levels of sensor expression in almost all tissues and cells, excluding erythrocytes and hair. For example, we found high fluorescence in the eye and the skin (Figure 1B), as well as in the brain, heart, kidney, and ileum (Figure 1C). Interestingly, transgenic mice did not show any abnormalities and had a normal life expectancy, demonstrating that the presence of the sensor in most cells of the organism did not interfere with its proper development and physiological functions. [Figure: Generation and characterization of CAG-Epac1-camps transgenic mice.(A) Expression cassette used to generate the transgenic mice. The cAMP sensor (Epac1-camps) contains a cAMP binding domain derived from Epac1, flanked on either side by YFP and CFP. The Epac1-camps sensor is under the control of the ubiquitous CAG promoter. (B) Fluorescent image of the head of a transgenic (TG) mouse compared to that of a wild-type (WT) littermate. (C) Fluorescent images of different organs isolated from adult TG and WT mice.] Real-Time cAMP Measurements Next, we isolated several types of embryonic and adult primary cells from CAG-Epac1-camps mice to measure cAMP levels in real time. cAMP levels were monitored by FRET microscopy on live cells as previously described [14]. From E14.5 embryos, we obtained murine embryonic fibroblasts (MEFs) and cortical neurons, which showed high fluorescence. Stimulation of MEFs with the β-adrenergic agonist isoproterenol resulted in a robust decrease of the YFP/CFP ratio (Figure 2A), indicative of an increase of cAMP levels [14]. As already reported in other cell types [24],[25], this response was transient, due to the protein kinase A (PKA)-dependent activation of phosphodiesterase 4 (PDE4), which could be counteracted by addition of a specific inhibitor (rolipram). In cortical neurons, isoproterenol induced a similar type of reaction, though of smaller amplitude. Like in MEFs, the response was transient and could be enhanced by addition of rolipram (Figure 2B). From adult mice, we isolated cardiac myocytes and peritoneal macrophages. In line with our previous observations [26], β-adrenergic stimulation of cardiac cells led to an increase of cAMP

Read the complete text